Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of HL-1186 for painful diabetic peripheral neuropathy
CTR20253202Phase 2Active
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HL-1186 in diabetic polyneuropathy (DPN), sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.. Started Sep 2025; status: active.
02
Drugs
HL-1186
03
Conditions
diabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on CTR20253202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253202.